Asthma is a serious health problem throughout the world. During the past two decades, many
scientific advances have improved our understanding of asthma and ability to manage and …

Severe or therapy-resistant asthma is increasingly recognised as a major unmet need. A
Task Force, supported by the European Respiratory Society and American Thoracic Society, …

For most patients, asthma is not controlled as defined by guidelines; whether this is achievable
has not been prospectively studied. A 1-year, randomized, stratified, double-blind, parallel…

Background: The assessment of asthma control is pivotal to the evaluation of treatment
response in individuals and in clinical trials. Previously, asthma control, severity, and …

The Global Initiative for Asthma (GINA) Strategy Report provides clinicians with an annually
updated evidence-based strategy for asthma management and prevention, which can be …

Background Asthma is a major cause of disability, health resource utilization and poor quality
of life world-wide. We set out to generate estimates of the global burden of asthma in adults…

Background Elevated numbers of blood eosinophils are a risk factor for asthma exacerbations.
Reslizumab is a humanised anti-interleukin 5 monoclonal antibody that disrupts …

The 7-item Asthma Control Questionnaire (ACQ) has been validated to measure the goals of
asthma management as defined by international guidelines (minimisation of day- and night-…

Despite the considerable progress in the classification of the idiopathic interstitial pneumonias
(IIPs), the lack of an international standard has resulted in variable and confusing …

Over the past 20 years, the Global Initiative for Asthma (GINA) has regularly published and
annually updated a global strategy for asthma management and prevention that has formed …